4/A
Changes in Ownership
Enliven Therapeutics, Inc. Filed Acc 0001415889-25-022649
PRESIDENT AND CEO sold 1,517 shares at $20.00 ($30,343)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Kintz Samuel · PRESIDENT AND CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-08-20 | Sale : show line 1 in the form 10b5-1 | −1,517 | $20.00 | $30,343 | 927,892 | I |
| Open-market sales · 1,517 sh · avg $20.00 · $30,343 | ||||||
Loading xslF345X05/form4a-08212025_100826.xml…